Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: A pilot study

Conclusion: This trial suggests greater rectal radioprotection from acute effects with 2 g vs. 1 g amifostine suspension. Further studies should be conducted in populations at higher risk for developing symptomatic acute and late proctitis.